Back
Graham Holdings 10K Form
Buy
52
GHC
Graham Holdings
Last Price:
945.98
Seasonality Move:
5.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | GHC/Graham Holdings Quarterly |
2023-11-01 | 10Q | GHC/Graham Holdings Quarterly |
2023-08-02 | 10Q | GHC/Graham Holdings Quarterly |
2023-05-03 | 10Q | GHC/Graham Holdings Quarterly |
2022-11-02 | 10Q | GHC/Graham Holdings Quarterly |
2022-08-03 | 10Q | GHC/Graham Holdings Quarterly |
Receive GHC News And Ratings
See the #1 stock for the next 7 days that we like better than GHC
GHC Financial Statistics
Sales & Book Value
Annual Sales: | $4.41B |
---|---|
Cash Flow: | $219.45M |
Price / Cash Flow: | 16.52 |
Annual Sales: | $921.06 |
Price / Book: | 1.04 |
Profitability
EPS (TTM): | 51.03000 |
---|---|
Net Income (TTM): | $229.1M |
Gross Margin: | $1.31B |
Return on Equity: | 5.74% |
Return on Assets: | 3.2% |
Graham Holdings Earnings Forecast
Key Graham Holdings Financial Ratios
- The Gross Profit Margin over the past 40 years for GHC is 29.72%.
- The Selling, General & Administrative Expenses for GHC have been equal to 22.82% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 30.84% of Operating Income.
- The Net Earning history of GHC is 4.65% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 24 years.
Graham Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Diversified Consumer Services |
Sector: | Consumer Discretionary |
Current Symbol: | GHC |
CUSIP: | 384637 |
Website: | ghco.com |
Debt
Debt-to-Equity Ratio: | 0.19 |
---|---|
Current Ratio: | 1.57 |
Quick Ratio: | 1.2 |
Price-to-Earnings
Trailing P/E Ratio: | 21.91 |
---|---|
Forward P/E Ratio: | 19.6 |
GHC Technical Analysis vs Fundamental Analysis
Buy
52
Graham Holdings (GHC)
is a Buy
Is Graham Holdings a Buy or a Sell?
-
Graham Holdings stock is rated a Buy
The current Graham Holdings [GHC] share price is $960.21. The Score for GHC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.